Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells

[1]  S. Terai,et al.  Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases , 2017, Inflammation and regeneration.

[2]  S. Terai,et al.  Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis , 2017, Journal of Gastroenterology.

[3]  A. Malik,et al.  TNFα-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury , 2016, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Ferrante,et al.  Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial , 2016, The Lancet.

[5]  Hong Xu,et al.  Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis , 2016, Experimental and therapeutic medicine.

[6]  N. Ishimaru,et al.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. , 2016, World journal of gastroenterology.

[7]  Roeland A Veenendaal,et al.  Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. , 2015, Gastroenterology.

[8]  S. Rutella,et al.  Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. , 2015, Gastroenterology.

[9]  T. Smyrk,et al.  Stem cells for murine interstitial cells of cajal suppress cellular immunity and colitis via prostaglandin E2 secretion. , 2015, Gastroenterology.

[10]  Maria Fichera,et al.  Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease. , 2015, The New England journal of medicine.

[11]  Wei Cao,et al.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications , 2014, Nature Immunology.

[12]  M. Fujimiya,et al.  Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors , 2014, Journal of Gastroenterology.

[13]  Y. Zhang,et al.  The interaction between mesenchymal stem cells and steroids during inflammation , 2014, Cell Death and Disease.

[14]  K. Kang,et al.  Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. , 2013, Gastroenterology.

[15]  Y. Cho,et al.  Autologous adipose tissue‐derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula , 2013, Stem cells.

[16]  N. Kosaka,et al.  The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles , 2013, Proteomics.

[17]  D. García-Olmo,et al.  Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial , 2013, International Journal of Colorectal Disease.

[18]  Y. Cho,et al.  Autologous Adipose Tissue-Derived Stem Cells for the Treatment of Crohn's Fistula: A Phase I Clinical Study , 2013, Cell transplantation.

[19]  Michael D. Kappelman,et al.  Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population , 2012, Digestive Diseases and Sciences.

[20]  S. Ichinose,et al.  Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell , 2012, Nature Medicine.

[21]  D. Hommes,et al.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study , 2010, Gut.

[22]  Yuji Nishiwaki,et al.  Prevalence of ulcerative colitis and Crohn’s disease in Japan , 2009, Journal of Gastroenterology.

[23]  Manuel A. González,et al.  Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. , 2009, Gastroenterology.

[24]  D. Büscher,et al.  Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis , 2009, Gut.

[25]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.

[26]  R. Sartor,et al.  Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. , 2001, Gastroenterology.

[27]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[28]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[29]  R. Herrmann,et al.  A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.